AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2010
Dec 17, 2010
29745_dirs_2010-12-17_216ef124-ad61-4b78-be3c-00926873bdad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2010-12-16
Reporting Person: Carmine Bryce D. (EVP and Pres, Lilly Bio-Meds)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-12-06 | Common Stock | G | 45 | $0.00 | Disposed | 63295 | Direct |
| 2010-12-07 | Common Stock | G | 60 | $0.00 | Disposed | 63235 | Direct |
| 2010-12-09 | Common Stock | G | 105 | $0.00 | Disposed | 63130 | Direct |
| 2010-12-16 | Common Stock | S | 3100 | $35.10 | Disposed | 60030 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6085 | Indirect |
Footnotes
F1: The transaction reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 1, 2010.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29